All stock lists
Maxcyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
Healthcare · Medical Devices
$1.25+$0.08 (+6.84%)
Insider Score
80/ 100
MXCT Insider Score
Bullish1 qualifying trade · 1 insider · $120.78K bought in the last 90 days
MXCT Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $10.15 M | $7.27 M | $9.65 M | $7.30 M | $6.83 M |
| Revenue Growth (YoY) | 48.66 % | — | — | — | — |
| Cost of Revenue | $1.68 M | $1.68 M | $1.57 M | $1.61 M | $1.60 M |
| Gross Profit | $8.47 M | $5.60 M | $8.08 M | $5.69 M | $5.23 M |
| SG&A Expense | $10.77 M | $10.62 M | $9.39 M | $8.99 M | $9.96 M |
| R&D Expense | $2.87 M | $4.25 M | $3.86 M | $3.33 M | $5.32 M |
| Operating Expenses | $14.51 M | $15.83 M | $14.27 M | $13.36 M | $16.32 M |
| Operating Income | -$6.04 M | -$10.23 M | -$6.18 M | -$7.67 M | -$11.09 M |
| Pretax Income | -$4.76 M | -$8.87 M | -$4.75 M | -$9.60 M | -$12.42 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.76 M | -$8.87 M | -$4.75 M | -$9.60 M | -$12.42 M |
| EPS (Basic) | -$0.05 | -$0.08 | -$0.04 | -$0.09 | -$0.12 |
| EPS (Diluted) | -$0.05 | -$0.08 | -$0.04 | -$0.09 | -$0.12 |
| Shares Outstanding | 103.54 M | 106.82 M | 106.88 M | 106.73 M | 106.61 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
